Seongnam-si
South Korea
15
2025-05-08
12
2024-10-22
These are the the leading inventors for applications assigned to ABL BIO INC.:
ABL BIO INC. based in Seongnam-si, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTI-PD-L1/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF
#2 | 2025-04-10BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF
#3 | 2024-10-22 ✅ Patent 12,122,830 granted on 2024-10-22Anti-ROR1 antibody and use thereof
#4 | 2024-08-27 ✅ Patent 12,071,483 granted on 2024-08-27Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereof
#5 | 2024-03-28 ✅ Patent 12,624,110 granted on 2026-05-12Bispecific Antibody to A-Syn/IGF1R and Use Thereof
#6 | 2024-02-06 ✅ Patent 11,891,445 granted on 2024-02-06Anti-B7-H3 antibody and use thereof
#7 | 2023-11-09BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF
#8 | 2023-07-20 ✅ Patent 12,049,493 granted on 2024-07-30Anti-alpha-synuclein antibodies and uses thereof
#9 | 2022-11-17 ✅ Patent 12,173,070 granted on 2024-12-24Anti-PD-L1/anti-LAG3 bispecific antibodies and uses thereof
#10 | 2022-11-03 ✅ Patent 12,577,313 granted on 2026-03-17ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF
#11 | 2022-08-04 ✅ Patent 12,195,537 granted on 2025-01-14Anti-4-1BB antibody and use thereof
#12 | 2022-02-24 ✅ Patent 12,195,538 granted on 2025-01-14Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereof
#13 | 2021-10-14 ✅ Patent 11,261,259 granted on 2022-03-01Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof
#14 | 2021-01-28 ✅ Patent 12,240,913 granted on 2025-03-04Anti-HER2/anti-4-1BB bispecific antibody and use thereof
#15 | 2021-01-28 ✅ Patent 12,168,690 granted on 2024-12-17Anti-EGFR/anti-4-1BB bispecific antibody
Also check out ABL Bio Inc.'s (Seongnam-Si, South Korea) applicant profile with 20 patent applications submitted.
343592 ⎘